BD (Becton, Dickinson and Company), a leading global medical technology company, announced the US Food and Drug Administration 510(k) clearance of its second generation BD Nano pen needle, designed ...
PARSIPPANY, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced a new landmark ...
A recent study by Grassi et al. has concluded that blood glucose control in diabetes patients who inject insulin can be improved through better injection technique, which includes switching patients ...